"I am a clinical investigator who specializes in the study and treatment of patients with lymphoma. My area of primary research is clinical and translational research in lymphoma. I have a strong interest in indolent and aggressive lymphomas, particularly in the implementation of quantitative FDG-PET/CT analysis in the risk stratification and evaluation of novel therapies in lymphoma patients".